美股与A股基本面因子不同，但科技与大宗商品等领域具有共同的发展趋势，可以作为A股投资逻辑的参考，如AI医疗、智能驾驶、数据中心、云计算。一、Tempus AI股价近期大幅上涨，主要由以下几方面因素推动：1. AI技术在医疗领域的应用前景Tempus ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care ...

Tempus AI , Inc. (NASDAQ: TEM )首席会计官Ryan M. Bartolucci于2025年2月13日出售了6,059股公司A类普通股。此次出售的时机值得注意，因为TEM股价在过去一周内已上涨超过21%，目前交易价格为$89.44，接近52周高点。这些股票以每股$80的价格售出，交易总额为$484,720。此次出售后，Bartolucci持有47,000股Tempus ...

There's still plenty of time for growth investors to click the buy button on Tempus AI stock; however, it's critical to recognize the road ahead may be rocky. Therefore, only those comfortable with an ...

Investing.com -- Tempus AI , Inc. (NASDAQ: TEM )周二盘前交易中股价上涨5%，此前该公司完成了对Ambry Genetics的收购。Ambry Genetics以其基因检测服务闻名，致力于研究基因与疾病之间的关系。此外，由于同为AI公司的Palantir收盘后发布强劲财报，也助推了Tempus AI的股价。Palantir盘前交易中上涨24%。

We recently published a list of Top 10 AI Stocks Trending On Wall Street. In this article, we are going to take a look at ...

Ryan M. Bartolucci, the Chief Accounting Officer of Tempus AI , Inc. (NASDAQ:TEM), sold 6,059 shares of the company's Class A ...

Up about 12%, Tempus AI (NASDAQ:TEM) has been explosive. Helping, its volume just spiked to 18.6 million shares, as compared ...

Tempus AI has delivered an 82% YTD return, outperforming the broader market and AI-themed stocks amidst market volatility.

(NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced it has completed its acquisition of Ambry Genetics, a recognized ...

Tempus AI (TEM) is soaring 13% today after investment bank TD Cowen reinstated coverage of the shares with a Buy rating. TEM ...

TD Cowen analyst Dan Brennan reinstated coverage of Tempus AI (TEM) with a Buy rating and price target of $74, up from $58, following the ...